Progressive Supranuclear Palsy clinical trials
21 active trials name this condition. Describe your situation to see which ones you may be eligible for.
By location
- A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
- Transcranial Magnetic Stimulation in Progressive Supranuclear Palsy
- Neurologic Stem Cell Treatment Study
- A Molecular Anatomic Imaging Analysis of Tau in Progressive Supranuclear Palsy
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake of 11C-HY-2-15
- Evaluation of Tau-Pathology in Sporadic and LRRK2 Parkinson's Disease
- CW2IP2: Imaging and Diagnostic Assessments
- PET Tau - Neurodegenerative Disease Imaging
- Study of Biodistribution, Metabolism, Excretion and Brain Uptake 18F-JSS20-183A
- The CurePSP Genetics Program
- Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
- NYSCF Scientific Discovery Biobank
- UPenn Observational Research Repository on Neurodegenerative Disease
- ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- Modifiable Variables in Parkinsonism (MVP)
- Remote Monitoring in Progressive Supranuclear Palsy (PSP)
- Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies
- Clinico-Pathologic-Genetic-Imaging Study of Neurodegenerative and Related Disorders
- Gait Analysis in Neurological Disease
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Progressive Supranuclear Palsy” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.